Total 23 patients with different malignancies viz. Ca. Lung (5), Ca. Uterine & Cervix (5), Ca. Head & Neck (5), Sarcomas (5) and Malignant Melanoma (3); were studied for spontaneous sister chromatid exchange frequencies (SCE) as well as cell cycle progression. All blood samples were collected prior to chemotherapy and/or radiotherapy to exclude the influence of these therapies, if any, on SCEs. Totally 15 healthy, age and sex matched individuals and belonging to the same socioeconomic status, but no direct relatives of the patients were studied simultaneously as controls. The SCE rates, when compared to controls (4.00 ± 0.39) were found to be significantly high for patients with Ca. lung (9.42 ± 1.20), malignant melanoma (8.14 ± 0.21), Ca. head & neck (6.85 ± 0.89) as well as sarcomas (6.29 ± 0.79). However, no detectable difference was observed in the SCE rate for patients with Ca. uterine & cervix (5.02 ± 0.88). Cell cycle proliferation and thereby replicative index was significantly elevated in patients with carcinoma of head & neck as well as malignant melanoma. On the other hand, rest of the patients showed no much variation in cell cycle progression when compared to controls.